BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Everett JR. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling. Handb Exp Pharmacol 2019;260:263-99. [PMID: 31823071 DOI: 10.1007/164_2019_316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Barrett JE, Page C, Michel MC. Perspectives of Pharmacology over the Past 100 Years. Handb Exp Pharmacol 2019;260:3-16. [PMID: 31823070 DOI: 10.1007/164_2019_334] [Reference Citation Analysis]
2 Kotsis F, Schultheiss UT, Wuttke M, Schlosser P, Mielke J, Becker MS, Oefner PJ, Karoly ED, Mohney RP, Eckardt KU, Sekula P, Köttgen A; GCKD Investigators. Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study. J Am Soc Nephrol 2021;32:2315-29. [PMID: 34140400 DOI: 10.1681/ASN.2021010063] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Molloy B, Mullin L, King A, Gethings LA, Plumb RS, Wilson ID. The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC-IM-MS Study. Metabolites 2021;11:379. [PMID: 34208076 DOI: 10.3390/metabo11060379] [Reference Citation Analysis]
4 Rivera-Velez SM, Navas J, Villarino NF. Applying metabolomics to veterinary pharmacology and therapeutics. J Vet Pharmacol Ther 2021. [PMID: 33719079 DOI: 10.1111/jvp.12961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]